couter

002332.SZZhejiang Xianju Pharmaceutical Co.,Ltd.

Health CarePharmaceuticals
Oct 15, 2026 — National VBP Policy Digest & Pricing Adjustments
Chart by TradingView

The schedule

  • Thu15Oct

    Market assimilation of the latest Volume-Based Procurement (VBP) pricing caps on generic and specialty formulations.

  • Mon25Jan

    Preliminary full-year 2026 results and forward management guidance on capital expenditure and API pipeline.

  • Fri26Feb

    Quarterly earnings report providing visibility into Q3 demand recovery and potential easing of YoY comparables.

  • Fri28May
  • Fri27Aug

    First-quarter 2027 financial release evaluating volume recovery across the specialty steroid product lines.

Past

  • Fri28Aug

    Actual outcome: Mixed · $8.54 at outcome

    Price at outcome date was between bear floor ($7.94) and bull target ($8.94).

    Expected announcement for H1/Q2 2026 financial results, assessing the continuation of the negative YoY revenue and net income trends.